Viviane Ferraz | Associate Director Patient Safety Scientist
Astra Zeneca

Viviane Ferraz is an accomplished Associate Director, Patient Safety Scientist at AstraZeneca, with a proven track record of excellence in pharmacovigilance and drug safety. With a strong background in life sciences and pharmaceuticals, she provides scientific leadership for vaccine and immune‑therapy programmes across development stages, supporting AZ V&I global development and access. Throughout her career, Viviane has played a key role in the research and development of vaccines, working closely with cross‑functional teams to bring innovative products to market. Her expertise in pharmacovigilance has been instrumental in identifying and mitigating potential risks associated with vaccine development, ensuring the highest standards of safety for patients worldwide. Dr. Ferraz -de- Paula earned her PhD in Neuroscience and Behavior from the University of São Paulo and spent more than a decade in academic research on neuroimmunomodulation, producing numerous publications and international presentations. She is fluent in Portuguese, Spanish, and English and has a proven track record of building international collaborations between clinical and scientific partners. Viviane is a dynamic and engaging speaker with a passion for sharing her knowledge and insights with industry peers. For this session on strategies for collaboration, equitable vaccine access, and global partnerships, Dr. Ferraz de Paula will guide the flow of discussion, draw links between industry, NGO, and public‑health perspectives, and surface practical lessons and partnership opportunities. Attendees can expect to gain valuable perspectives on the latest trends and challenges in vaccine development, as well as practical strategies for driving innovation and collaboration in the field.